2.2098 -0.01 (-0.46%)
After hours: 4:47PM EST
|Bid||2.2000 x 3000|
|Ask||2.2100 x 3200|
|Day's Range||2.0800 - 2.2600|
|52 Week Range||1.6600 - 6.6900|
|Beta (5Y Monthly)||2.16|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 13, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||6.00|
DENVER, Feb. 19, 2020 -- NewAge Beverages Corporation (Nasdaq: NBEV), the Colorado-based healthy products company, today announced the launch of their CBD beverage Noni+CBD in.
NewAge Beverages Corporation (NBEV), the Colorado-based healthy products company, today announced that David Vanderveen has joined NewAge as the newly appointed chief operating officer effective immediately. David Vanderveen has been an accomplished industry leader in the Direct Selling industry for over 20 years. Since the sale of XS Energy, he has been operating as a senior executive within Amway leading the expansion of the brand to more than 60 countries.
DENVER, Jan. 09, 2020 -- NewAge Beverages Corporation (Nasdaq: NBEV), the Colorado-based healthy products company, today announced that it will present and meet with investors.
NewAge Beverages Corporation (NBEV), the Colorado-based healthy products company, today announced that Alicia Syrett has joined New Age as a newly appointed member of the Board of Directors effective January 6, 2020. Ms. Syrett intends to stand for election to the NewAge Board of Directors at its annual meeting to be held in May 2020. Ms. Syrett brings more than 20 years of investment management experience to the NewAge Board and is currently the Chief Executive Officer of Pantegrion Capital, an investment management firm she founded in 2011.
In 2016 Brent Willis was appointed CEO of New Age Beverages Corporation (NASDAQ:NBEV). This report will, first...
Without knowing hardly anything about New Age Beverages (NASDAQ:NBEV), you already know that it's an extremely risky trade. With 2019 coming to a close shortly, NBEV stock is down an alarming 59%.Source: Shutterstock Since February - and with a brief respite in the spring season - shares have consistently declined. As our own Laura Hoy described, it's a classic falling knife.Despite the ugliness in New Age Beverages stock, though, the underlying company undeniably carries speculative appeal. First, NBEV offers multiple beverage brands, with many focusing on the health aspect. And that's a huge positive considering the current trends in the beverage marketplace. After all, consumers not only want health drinks but they're willing to pay the premium.InvestorPlace - Stock Market News, Stock Advice & Trading TipsFurthermore, NBEV stock is levered to the cannabidiol or CBD business via the organization's Marley brand. Thanks to the groundbreaking Agriculture Improvement Act of 2018 (also known as the farm bill), hemp and hemp-derivatives like CBD are federally legal, so long as they don't contain more than 0.3% tetrahydrocannabinol (THC) content. * 7 Vaping Stocks to Get into Ahead of the Crowd That passing of the farm bill opened the floodgates to a whole new industry. On paper, this bodes well for New Age Beverages stock, considering its desirable Marley brand. However, as you can see from the share price, things haven't panned out as planned. For NBEV Stock, the Problems Are RealNo matter how enticing the narrative sounds, at some point, cannabis-related companies must deliver the goods. Failing that, they've got to demonstrate a reasonable pathway to sustainable growth and profitability to keep stakeholders interested.For New Age Beverages stock, this a problem on both fronts. Again, on paper, the revenue growth appears very impressive. However, as InvestorPlace contributor Vince Martin points out, this year's top-line sales growth "all came through acquisitions, as detailed in an SEC filing. Morinda, purchased a year ago, contributed $54.8 million in sales. Brands Within Reach, picked up in June, added $2.4 million of revenue."Minus the buyouts, revenue growth does not look impressive; indeed, quite the opposite. Martin further notes that:The legacy New Age business posted sales of $12.6 million, about 5% below last year's total. And its revenue should not be shrinking. New deals with the likes of Walmart (NYSE:WMT) and 7-Eleven (OTCMKTS:SVNDY) were supposed to drive higher sales.If these were the only headwinds against NBEV stock, it'd be bad enough. However, Hoy asserts that management created unnecessary roadblocks for themselves. She wrote:…management has poorly executed its strategy in North America. Until now, the firm only had a "sales team of 2 or 3" in North America-- a questionable way to manage a segment that the firm itself said was expanding rapidly as the company makes inroads into several different businesses.Unsurprisingly, then, the profitability picture for NBEV stock currently looks poor. Losses are widening while long-term debt has expanded. And its products don't appear to be gaining traction as you might expect. But the Opportunities Are Real TooSource: Chart by Josh Enomoto Despite the mismanagement and misfires, New Age still has the Marley brand. While it's not wise to bank on any one asset, investors may not appreciate how powerful this brand is.In the U.S., experts forecast that the value of the CBD-infused beverages market will hit $227 million. By the end of next year, it should reach $472 million. And by 2023, this segment will make significant noise as a $1.4 billion market.Granted, this is pennies compared to the global beverages' arena. However, New Age doesn't need to take over the world. Given their small fiscal footprint relative to the beverage giants, NBEV just needs to make an impact in the North American sector.That's a much more reasonable objective, which does bode well for New Age Beverages stock. As I said, the underlying company has the Marley brand, and from what I'm seeing in the beverage space, branding is everything.As several analysts have noted, consumers (particularly Millennials) have gravitated toward health-related drinks. But I can make the case that consumers are actually gravitating toward the perception of health.Case in point is Coca-Cola (NYSE:KO). In recent quarters, the soft drink behemoth has strung together impressive earnings results. As I mentioned last year, one of Coca-Cola's most conspicuous rebranding efforts involved packaging their Diet Coke drinks in tall, lithe cans brimming with bright colors.We know this crap isn't healthy. Furthermore, Coca-Cola represents big business, hardly a Millennial attribute. Yet the power of this new Diet Coke brand rejuvenated a company that had no business of being rejuvenated.Imagine what would happen if NBEV management got their act together? The Marley brand could skyrocket NBEV stock. An Ultra-Speculative Bet, but with a ShotPlease don't mistake the investment profile of New Age Beverages stock: this is a risky gamble. Even if you were confidently bullish, it's not something you play with other than with "dumb money."That said, among stupid bets, NBEV stock has a believable catalyst. It just needs to survive some ugly challenges, which of course is no guarantee.As of this writing, Josh Enomoto did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * The 8 Biggest Investing Surprises of 2019 * 7 Impressive Stocks to Buy Over $250 * 4 Small-Cap Energy Stocks Ready to Explode The post As Bad as the Risk/Reward Looks, There Is an Argument for NBEV Stock appeared first on InvestorPlace.
We at Insider Monkey have gone over 752 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of September 30th. In this article, we look at what those funds think of New Age Beverages Corporation (NASDAQ:NBEV) based on […]
DENVER, COLORADO, Dec. 20, 2019 -- NEWAGE (NASDAQ: NBEV), the Colorado-based healthy products company, announced the launch of its hemp portfolio in Australia and New Zealand..
As retail traders have become more sophisticated and online trading platforms have offered more features, short selling has become an increasingly popular way for traders to profit off of a stock’s downturn. ...
It’s safe to say things aren’t so rosy for New Age Beverages (NBEV) stock. Shares have plummeted around 65% year-to-date in line with the trajectory of the cannabis industry in general.The company’s latest earnings report was a mixed affair. Q3 revenue increased from $13.2 million in the same period last year to $69.8 million, though the figure came in slightly below the Street’s $69.95 million estimate. The net loss, though, of $10.7 million, or $0.14 per share was bigger than the Street’s estimate of -$0.04 per share.The pertinent question right now is: Has NBEV stock bottomed out?Compass Point’s Rommel Dionisio remains bullish on NBEV’s prospects. The 4-star analyst notes that a combination of an expanding distribution platform in both the traditional retail and direct-to-consumer channels, new product introductions driving organic sales growth, and successful acquisitions such as the recent Morinda transaction, have all contributed to NBEV’s status as “one of the fastest growing beverage companies in the US in recent years.”The analyst also notes the company’s growing offerings of CBD related products as “a major near-term growth opportunity.” Dionisio concluded, “By leveraging the company's traditional retail channels in North America as well as Morinda's direct sales force in Asia, and with rapidly growing consumer acceptance around the world of the potential benefits of CBD, New Age Beverages appears well positioned to generate significant top and bottom line growth in upcoming quarters, especially once the FDA provides guidelines permitting the sale of CBD beverages and edibles.”Fittingly, Dionisio reiterates a Buy rating on NBEV alongside a bullish price target of $9.00 which could provide enormous gains of 390% from current levles. (To watch Dionisio’s track record, click here)On the other hand, Northland’s Mike Grondahl sounds a more cautious note, saying, “Morinda acquisition integration sounds fine, however, Morinda sales in China continue to be down significantly y/y due to government restrictions on MLM industry and this will probably take China from ~$80M in 2018 to ~ $50M in 2019 but September y/y were up 5% for first month of growth this year.” Furthermore, "NBEV noted WMT and 7-11 were performing below expectations. It sounds like while both retailers have blessed NBEV products, but getting products on the shelf has been challenging and that will remain a work-in-progress. It sounds like this is not a catalyst for NBEV."The 5-star analyst reiterated a Market Perform rating on NBEV, alongside a price target of $3.50. Interestingly, due to the stock’s horror of a year, the target represents a substantial upside potential of about 90%. (To watch Grondahl’s track record, click here)There is only one other analyst (from Roth Capital) currently chipping in with a view on the beverage company’s prospects, adding a further Buy rating. The consensus marks the stock as a Moderate Buy, with an average price target of $6.83, providing the risk tolerant investor massive potential gains of 272%. (See NBEV price targets and analyst ratings on TipRanks)To find good ideas for cannabis stocks trading at fair value or better, visit TipRanks’ Best Stocks to Buy, a newly launched tool that unites all of TipRanks’ equity insights.
Money flows are mostly negative or neutral in marijuana stocks, and the Food and Drug Administration’s warning is creating an overhang.
Ask Benjamin Witte about Recess, and one of the first places he’ll send you is the company’s Instagram page.
DENVER, COLORADO, Nov. 14, 2019 -- NEWAGE (NASDAQ: NBEV), the Colorado-based healthy products company, today announced financial results for the quarter ended September 30,.
Thanks to both Canadian legalization as well as the 2018 farm bill here in the states, North America has essentially become "little Amsterdam." Moreover, favorably shifting public sentiment in the U.S. has made cannabis-infused beverage companies like New Age Beverages (NASDAQ:NBEV) intriguing for both consumers and investors alike. Particularly, NBEV stock appeals for the underlying broad mixture of cannabis and general health-related drinks.Source: monticello / Shutterstock.com Still, cannabis stocks are infamous for their volatility. Due to myriad challenges, along with questions about the industry's financial viability, several investors have dumped out of their positions. Despite New Age Beverages stock not being a pure cannabis play, shares have not received an exemption from the pain. Naturally, investors remain unsure how to approach NBEV.Further adding to the pressure, New Age will release its third-quarter earnings results on Nov. 14 before the opening bell. Since Q2 2017, the company has failed to deliver positive earnings per share. As such, investors will likely want to see some meaningful pathway toward profitability for NBEV stock.InvestorPlace - Stock Market News, Stock Advice & Trading TipsGiven the rough waters of the broader cannabis industry, it's difficult to guess how the markets will respond on Thursday. Still, legal cannabis products, especially cannabis-infused beverages are incredibly popular. With that, here are three arguments for and against New Age Beverages stock: Pros: Strong Projected Growth for Cannabis BeveragesCannabis-based beverages, specifically cannabidiol or CBD-infused drinks, will be huge in the U.S. According to research firm Zenith Global, this market will hit a value of $1.4 billion at the end of 2023. To put this into context, Zenith projects CBD beverages to reach $227 million at the end of this year. * 7 Tech Stocks You Should Avoid Now In addition, companies like New Age have the opportunity to convert curious newcomers to cannabis-based products and therapies. According to an August 2019 Gallup poll, 14% of Americans say they use CBD. While impressive, this figure also leaves an ample opportunity for New Age to advantage, potentially lifting NBEV stock.Not only that, High Yield Insights performed a study revealing that the most popular CBD products are baked goods. Coming in second place are CBD gummies. While not beverages, these are consumable formats with which everyone is familiar.Therefore, it's not a stretch to assume that the folks who like CBD edibles will eventually make the switch to CBD-infused beverages. That's a potential net positive for New Age Beverages stock. Pros: American Market Wide Open for NBEV StockRecently, I interviewed Marty Sumichrast, chairman and co-CEO of cbdMD (NYSEAMERICAN:YCBD). In our long-format discussion, Sumichrast mentioned that the U.S. market is wide open. Furthermore, he argues that Americans prefer CBD to tetrahydrocannabinol (THC)-based botanicals.Combined with the company's impressive array of products, this dynamic places cbdMD in a position to become the dominant CBD brand in the U.S.As a shareholder of YCBD, I wish them well. However, because the U.S. market is so open without an established dominant player, it allows companies like New Age to carve out a niche in a specific sub-segment like CBD-infused beverages. Pros: New Age Beverage Stock Isn't a Pure Cannabis PlayAlthough heavily associated with CBD, NBEV stock isn't purely a CBD investment. And right now, I'd say that fact offers some key advantages.Namely, New Age hasn't followed its cannabis peers in aggressive fiscal maneuvering. Although the company hasn't been profitable in a while, you can clearly see the pathway to eventual profitability. Primarily, NBEV features strong revenue growth and reasonable expenses.Also, New Age has a relatively solid balance sheet, highlighted by nearly $84 million in cash and only $13.4 million in long-term debt. Combined with its long-term capital lease obligations, these liabilities amount to $60.5 million.Simply put, management isn't making wild swings. At this point, that's a positive for NBEV stock. Cons: Legal Uncertainty in U.S. CBD MarketDespite much potential, New Age hasn't yet entered the CBD-infused beverage space in the U.S. Why? Management has blamed a "murky" legal environment.I don't fault them. Under the 2018 farm bill, industrial hemp and hemp-derived products are legal for individuals to purchase. But that doesn't necessarily mean that CBD is legal. After all, cannabis is still considered a Schedule I drug.How do American companies get around this tricky situation? CBD derived from hemp is permissible under the farm bill. However, CBD from any other source -- even if it contains less than 0.3% THC as mandated by the law -- is illegal.Even when you have everything right, CBD laws are still very confusing and perhaps contradictory. Because of this uncertainty, New Age Beverages stock risks losing momentum to competitors. Cons: Too Many AssumptionsAs enticing as CBD beverages are, nobody really knows how the market will respond. Though enticing for those looking for a non-offensive way to enjoy cannabis, CBD-infused drinks could end up becoming a fad.More critically, CBD itself could also become a fad. While I don't think this will be the case, I concede that the medical community is hesitant about endorsing CBD. Further research is necessary for medical professionals to feel comfortable prescribing cannabidiol or other cannabis-based therapies.Until that happens, NBEV stock has a fundamental risk associated with it. Cons: Big-Name CompetitionAs with most good ideas, NBEV isn't the only one pursing cannabis-infused beverages. Several players are involved in the CBD beverage space, most notably the joint partnership between Molson Coors Brewing (NYSE:TAP) and Hexo (NYSE:HEXO).Depending on how popular CBD-infused beverages become, other big players might enter the space. This could either be positive for New Age Beverages stock (i.e., a buyout) or it could be negative. Frankly, if larger players enter the space, they could use their leverage to build out a new brand.Also, the fact that NBEV is stalling in the U.S. market isn't a great confidence booster. Final AssessmentNew Age Beverages stock is a risk, but a compelling one. With the right amount of luck, shares can take off thanks to its powerful CBD brand. And because the U.S. market is ripe for the taking, the possibilities are endless.However, NBEV stock falls short because of the legality issue of CBD. And while I'm enthusiastic about CBD-infused beverages, the industry has question marks about viability.Ultimately, though, a lot of the bad news is baked into the price. If you can stomach the risk, NBEV stock is worth a careful, measured shot.As of this writing, Josh Enomoto is long YCBD and HEXO. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Large-Cap Stocks to Give a Wide Berth * 7 Potential New Stocks That Should Not Go Public * 5 Chinese Stocks to Buy Surging Higher The post 3 Pros, 3 Cons for New Age Beverages Stock appeared first on InvestorPlace.
New Age Beverages' (NBEV) third-quarter 2019 results might reflect gains from buyouts and a robust brand portfolio. However, higher costs might remain deterrents.
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and deteriorating expectations towards the resolution of the trade war with China, many smart money investors kept their cautious approach regarding the current bull run in the second quarter and hedging or reducing many of […]